31 Million Girls Suffer from PMDD: Know About the Disease and Proactive Tips for Relief

Arecent global study led by Dr. Thomas Reilly from the University of Oxford’s Department of Psychiatry has shed light on the prevalence of Premenstrual Dysphoric Disorder (PMDD) among women and girls worldwide.

The findings reveal that approximately 1.6% of females, equivalent to 31 million globally, meet the strict diagnostic criteria for PMDD. This severe and chronic medical condition demands attention, understanding, and effective management strategies.

Understanding PMDD

PMDD is not merely a medicalisation of normal menstrual symptoms nor a culturally bound syndrome specific to Western societies, as some misconceptions suggest. It is a genuine and debilitating health condition that significantly affects the lives of those who experience it.

The disorder is characterised by severe mood changes, including depression and anxiety, accompanied by physical symptoms such as breast tenderness and joint pain. Additionally, cognitive issues like difficulty concentrating or memory complaints are common manifestations.

Global Prevalence

The study, which analysed data from 50,659 female participants across six continents, challenges the notion that PMDD is limited to specific cultural or geographical regions.

The findings indicate that 3.2% had provisional diagnoses, signifying suspected cases where symptoms had not been consistently measured for a sustained period to confirm a diagnosis. This highlights the importance of recognising and addressing PMDD as a global health concern.